These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11920587)
1. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Herold-Mende C; Mueller MM; Bonsanto MM; Schmitt HP; Kunze S; Steiner HH Int J Cancer; 2002 Mar; 98(3):362-9. PubMed ID: 11920587 [TBL] [Abstract][Full Text] [Related]
2. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494 [TBL] [Abstract][Full Text] [Related]
3. Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue. Hirata E; Arakawa Y; Shirahata M; Yamaguchi M; Kishi Y; Okada T; Takahashi JA; Matsuda M; Hashimoto N Cancer Sci; 2009 Aug; 100(8):1451-9. PubMed ID: 19459858 [TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Higuchi M; Ohnishi T; Arita N; Hiraga S; Hayakawa T Acta Neuropathol; 1993; 85(5):481-7. PubMed ID: 7684178 [TBL] [Abstract][Full Text] [Related]
6. Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro. Martina E; Degen M; Rüegg C; Merlo A; Lino MM; Chiquet-Ehrismann R; Brellier F FASEB J; 2010 Mar; 24(3):778-87. PubMed ID: 19884327 [TBL] [Abstract][Full Text] [Related]
7. Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas. Kulla A; Liigant A; Piirsoo A; Rippin G; Asser T Mod Pathol; 2000 Jan; 13(1):56-67. PubMed ID: 10658911 [TBL] [Abstract][Full Text] [Related]
8. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays. Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866 [TBL] [Abstract][Full Text] [Related]
9. Tenascin-C Function in Glioma: Immunomodulation and Beyond. Yalcin F; Dzaye O; Xia S Adv Exp Med Biol; 2020; 1272():149-172. PubMed ID: 32845507 [TBL] [Abstract][Full Text] [Related]
10. Tenascin distribution in human brain tumours. Castellani P; Dorcaratto A; Siri A; Zardi L; Viale GL Acta Neurochir (Wien); 1995; 136(1-2):44-50. PubMed ID: 8748826 [TBL] [Abstract][Full Text] [Related]
11. Role of tenascins in the ECM of gliomas. Brösicke N; Faissner A Cell Adh Migr; 2015; 9(1-2):131-40. PubMed ID: 25695402 [TBL] [Abstract][Full Text] [Related]
12. Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels. Brösicke N; van Landeghem FK; Scheffler B; Faissner A Cell Tissue Res; 2013 Nov; 354(2):409-30. PubMed ID: 23963648 [TBL] [Abstract][Full Text] [Related]
13. Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells. Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Nagai R; Kudo C; Sasada M; Kodama H; Fukai F Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261783 [TBL] [Abstract][Full Text] [Related]
14. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Mai J; Sameni M; Mikkelsen T; Sloane BF Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of a glioblastoma-associated tenascin-C isoform in cerebral cavernomas and neighboring vessels. Viale GL; Castellani P; Dorcaratto A; Pau A; Sehrbundt E; Siri A; Birò A; Zardi L Neurosurgery; 2002 Apr; 50(4):838-42; discussion 842. PubMed ID: 11904036 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma. Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899 [TBL] [Abstract][Full Text] [Related]
18. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628 [TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression. Huang JY; Cheng YJ; Lin YP; Lin HC; Su CC; Juliano R; Yang BC J Immunol; 2010 Aug; 185(3):1450-9. PubMed ID: 20622113 [TBL] [Abstract][Full Text] [Related]
20. CD44 in human glioma correlates with histopathological grade and cell migration. Yoshida T; Matsuda Y; Naito Z; Ishiwata T Pathol Int; 2012 Jul; 62(7):463-70. PubMed ID: 22726066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]